The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Zim Laboratories Ltd

Zim Laboratories Ltd

BSE 541400 · NSE ZIMLAB · ISIN INE518E01015 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹125.00

+0.16%

BSE close, 28 August 2026

Market cap

₹670.73 cr

5.4 cr shares · Micro cap

Free float

₹411.09 cr

as published

P/E · P/B

176.1× · 2.86×

EPS ₹0.71 · BV ₹43.71

FY25-26 rev / PAT

370.48 / 5.97

₹ cr, as filed

Filings, window

15

4 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹59.72 52-WK HIGH ₹133.95 ₹125.00 88% of range
Against 52-week high-6.7%
Against 52-week low+109.3%
Day change+0.16%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.71
Price / earnings176.06×
Price / book2.86×
Book value — derived, price ÷ P/B₹43.71
Return on equity1.61%
Operating margin3.65%
Net margin-4.17%

Consistency check

P/B ÷ P/E, which must equal ROE
1.62%
ROE as published
1.61%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 93.05 -3.88 -0.72 3.65% -4.17%
Mar-26 · Q 102.85 3.28 0.67 12.38% 3.19%
FY25-26 370.48 5.97 1.22 11.06% 1.61%

Quarter on quarter

Revenue, quarter on quarter
-9.5%
Net profit, quarter on quarter
-218.3%
Operating margin, quarter on quarter
-873 bps

Disclosure profile 15 filings in the window

0 median 17.0 p75 · 25 sector max 52 15 43th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Concall Transcript1
Credit Rating1
Results1
Selected sub-total4
Procedural
Newspaper Publication2
Postal Ballot2
Subsidiary Incorporation2
Analyst / Investor Meet1
Board Meeting1
Compliance Certificate1
General1
Trading Window1
Procedural sub-total11
Total15

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

15 filings · 4 selected · busiest 2026-08-06 and 2026-08-12

Filing rhythm · the twelve most recent

2026-08-062026-10-08

SelectedProcedural

Filings

15 in the window · 15 earlier on record

  1. 8 October 2026 ·

    Credit Rating

    Credit Rating

    Please find enclosed the disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding Credit Rating

    Company Update / Credit Rating View filing →

  2. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended 30th September,2026 is enclosed herewith .

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  3. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Please find enclosed the intimation regarding the closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 18 September 2026 ·

    Subsidiary Incorporation

    Updates on Acquisition

    Intimation for incorporation of wholly owned subsidiary

    Company Update / Acquisition View filing →

  5. 15 September 2026 ·

    Subsidiary Incorporation

    Updates on Acquisition

    Update on completion of investment in the share capitalof ZIM Scientific Office L.L.C. (Step Down Subsidiary) by ZIM Laboratories Limited FZE, wholly owned subsidiary

    Company Update / Acquisition View filing →

  6. 12 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Q1 FY27 Earning Conference call

    Company Update / Earnings Call Transcript View filing →

  7. 12 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Please find enclosed the Scrutinizer's Report and Voting Results of Postal Ballot.

    AGM/EGM / Postal Ballot View filing →

  8. 12 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Please find enclosed the Outcome of Postal Ballot .

    AGM/EGM / Postal Ballot View filing →

  9. 7 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find enclosed the copy of Newspaper Publication for the financial results for the quarter ended 30th June 2026.

    Company Update / Newspaper Publication View filing →

  10. 6 August 2026 ·

    General

    Earnings Presentation - Q1 FY27

    Please find enclosed the disclosure under Regulation 30 of SEBI LODR Regulations regarding Earnings Presentation for Q1 FY 27

    Company Update / General View filing →

  11. 6 August 2026 ·

    Results

    Results-Financial Results For 30.06.2026.

    Please find enclosed the Unaudited Financial Results for the Quarter ended 30th June 2026.

    Result / Financial Results View filing →

  12. 6 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting.

    Please find enclosed the Financial Results for the Quarter ended 30th June 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 4 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find attached disclosure under Regulation 30 read with Scheduled III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Earnings Conference Call for ....

    Company Update / Analyst / Investor Meet View filing →

  14. 31 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30Th June, 2026.

    Zim Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

    Board Meeting / Board Meeting View filing →

  15. 30 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find enclosed the disclosure newspaper publication regarding intimation to the shareholder regarding transfer of shares to IEPF Authority

    Company Update / Newspaper Publication View filing →

RSS feed for Zim Laboratories Ltd · the 50 most recent filings